Trending News Today: Hormone Therapy Linked to Dementia

A new study has found that hormone therapy for prostate cancer is associated with an increased risk of dementia, according to The New York Times. The study, published in the JAMA Network Open, included approximately 154,089 men whose average age was 74 and who had diagnoses of prostate cancer. Compared with men who had no hormone therapy, 1 to 4 doses of ADT was associated with a 19% increased risk for both Alzheimer disease and other forms of dementia, and the risk increased with the number of doses.
Cancer took more than 8.7 million years of life and $94.4 billion in lost earnings among people ages 16 to 84 in the United States in 2015, according to a report through the American Cancer Society. In order to update estimated lost earnings due to death from cancer, the study authors calculated person-years of life lost using numbers of cancer deaths and life expectancy data. There were a total of 492,146 cancer deaths that occurred in 2015 and there was an approximate $191,900 over lost earnings per death.
New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer, according to the MD Anderson Cancer Center. The data suggest that the 3-drug therapy combination, encorafenib, binimetinib, and cetuximab, should replace chemotherapy for the 1 in 7 patients with metastatic colorectal cancer who have a BRAF mutation. The results of the trial indicated an improved overall survival and objective response compared with standard care.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.